eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » GlaxoSmithKline - Comment

GlaxoSmithKline - Comment

Document ID: FDA-2011-N-0080-0003
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: September 08 2011, at 12:00 AM Eastern Daylight Time
Date Posted: September 29 2011, at 12:00 AM Eastern Standard Time
Comment Start Date: June 21 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: September 19 2011, at 11:59 PM Eastern Standard Time
Tracking Number: 80f14186
View Document:  View as format xml

View Comment

See attached file(s)

Attachments:

GlaxoSmithKline - Comment, GSK Comments Proposed Sterility Testing Amendments_2011

Title:
GlaxoSmithKline - Comment, GSK Comments Proposed Sterility Testing Amendments_2011

View Attachment: View as format pdf

Related Comments

    View All
Total: 17
GlaxoSmithKline - Comment
Public Submission    Posted: 09/29/2011     ID: FDA-2011-N-0080-0003

Sep 19,2011 11:59 PM ET
Novo Nordisk Inc. - Comment
Public Submission    Posted: 09/29/2011     ID: FDA-2011-N-0080-0004

Sep 19,2011 11:59 PM ET
Celgene Corporation - Comment
Public Submission    Posted: 09/29/2011     ID: FDA-2011-N-0080-0005

Sep 19,2011 11:59 PM ET
ISPE - Comment
Public Submission    Posted: 09/29/2011     ID: FDA-2011-N-0080-0006

Sep 19,2011 11:59 PM ET
Pfizer Inc. - Comment
Public Submission    Posted: 09/29/2011     ID: FDA-2011-N-0080-0008

Sep 19,2011 11:59 PM ET